Anti-diabetic drugs Flashcards
Metformin
Mechanism
SE
Lower doses/monitoring in which patient populations
Mechanism
- Inhibits glucose output from the li version (unknown)
- Lowers plasma glucose
SE
- G.I.
- Lactic acidosis
Minimize SE by
- Minimized by taking medication with meals (before of after
Lower doses/monitoring in which patient populations
- Impaired hepatic/renal function and in alcoholics & cardiac insufficiency
Dehydration
Benefits of metformin over insulin
No risk of weight gain or hypoglycemia
Sulfonylurea
Mechanism
SE
Mechanism
- Bind to receptor that regulates and block K channels in pancreatic B-cell so intracellular K rises, Ca channel opens & triggers insulin release
SE
- Hypoglycemia
- Difficulty losing weight
- Some patients do not respond to sulfonylureas (primary failure). In addition, diabetes generally progresses in patients that do demonstrate an initial response (~5% per year secondary failure).
- Rare side effects include hematological or hepatic effects, CNS effects (dizziness, confusion), and dermatological effects (rash).
Metformin can be used with
sulfonylureas
Longest acting sulfonylurease
Glyburide
Shortest acting sulfonylurease
glipizide
Exenatide
Mechanism
Used in combination with
Mechanism
- Analog to incretinGLP-1 which increases insulin secretion
Combination
- Metformin & sulfonylureas
Thiazonlidinedione
Mechanism
SE
Mechanism
- Sensitize muscles, fat & liver to actions of insulin using
- GLUT 2 inhibitors
- Activates PPAR gamma & RXR
SE
- Weight gain
- Fluid retention
Best initial therapy
Metformin
Lowest cost add on drug
sulfonylurea
Second line add on drug
Thiazolidinedione